Patients often don’t realize that the same procedure at different locations (even with the same insurance) can have very ...

Inavolisib (Itovebi) is a new targeted therapy for HR+ HER2-negative metastatic breast cancer with a PIK3CA mutation.

Jessie J shares ‘lows and highs’ of breast cancer journey following surgery - The Price Tag singer announced in early June ...

The Innovation Center of NanoMedicine has summarized the results of its collaborative research with Professor Kanjiro ...

Christ Community Health partnered with Piedmont Augusta and the Georgia Department of Public Health to offer free breast cancer screenings on Monday.

Research presented at the ASCO Annual Meeting 2025 highlighted new potential standards of care and other advances in breast cancer.

Decision-making was influenced by patient values and did not vary by stage, race and ethnicity, or demographics ...

A study has found that venom from an Amazonian scorpion may kill breast cancer cells, offering hope for a new treatment ...

University of Cambridge study shows how LLM GPT-4 can generate novel combinations of drugs not typically used to treat cancer ...

Ananda Lewis chose alternative breast cancer treatments for years before her death this month. Here’s what she tried and what ...

Dr Heather McArthur describes how ASCO 2025 showcased new standards of care in triple-negative and HER2-positive settings.